Dendrimers: An innovative and enhanced ocular drug delivery system

Ophthalmic Drug Delivery Systems, Second Edition, Revised and Expanded

Volumn , Issue , 2003, Pages 467-492

  Loutsch, Jeannette M ^a   Ong, Desiree ^a   Hill, James M ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863384284     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Olejnik, O. (1993). Conventional systems in ophthalmic drug delivery. In: A. K. Mitra (ed.), Ophthalmic Drug Delivery Systems. Marcel Dekker, Inc., New York, p. 177.
2. Bawa, R. (1993). Ocular insert. In: Ophthalmic Drug Delivery Systems.A. K. Mitra (ed.). Marcel Dekker, Inc., New York, p. 223.
3. Hill, J. M., O’Callaghan, R. J., Hobden, J. A., and Kaufman, H. E. (1993). Corneal collagen shields for ocular drug delivery. In: Ophthalmic Drug Delivery Systems.A. K. Mitra (ed.). Marcel Dekker, Inc., New York, p. 261.
4. Davies, N. M., Kellaway, I. W., Greaves, J. L., and Wilson, C. G. (1993). Advanced corneal delivery systems: liposomes. In: Ophthalmic Drug Delivery Systems.A. K Mitra (ed.). Marcel Dekker, Inc., New York, p. 289.
5. Hill, J. M., O’Callaghan, R. J., and Hobden, J. A. (1993). Ocular iontophoresis. In: Ophthalmic Drug Delivery Systems.A. K. Mitra (ed.). Marcel Dekker, Inc., New York, p. 331.
6. Hill, J. M., O’Callaghan, R. J., Hobden, J. A., and Kaufman, H. E. Collagen shields for ocular drug delivery. In: Ophthalmic Drug Delivery Systems. M. K. Mitra (ed.). Marcel Dekker, Inc., New York, p. 261.
7. Tomalia, D. A. (1995). Dendrimer molecules. Sci. Am., 5: 42.
8. Tomalia, D. A., and Brothers, H. M. I. (1998). Regiospecific conjugation to dendritic polymers to produce nanodevices. In: Biological Molecules in Nanotechnology: The Convergence of Biotechnology, Polymer Chemistry, and Material Science.International Business Communications, Inc., Southborough, MA, pp. 107-120.
9. Flory, P. J. (1941). Molecular size distribution in three dimensional polymers. I. Gelation. J. Am. Chem. Soc., 63: 3083-3090.
10. Flory, P. J. (1941). Molecular size distribution in three dimensional polymers. II. Trifunctional branching units. J. Am. Chem. Soc., 63: 3091-3096.
11. Flory, P. J. (1941). Molecular size distribution in three dimensional polymers. III. Tetrafunctional branching units. J. Am. Chem. Soc., 63: 3096-3100.
12. Stockmayer, W. H. (1943). Theory of molecular size distribution and gel formation in branched-chain polymers. J. Chem. Phys., 11: 45-55.
13. Stockmayer, W. H. (1944). Theory of molecular size distribution and gel formation in branched polymers. II. General cross linking. J. Chem. Phys., 12: 125-131.
14. Buhleier, E., Wehner, W., and Vogtle, F. (1978). “Cascade”- and “nonskid-chain-like” syntheses of molecular cavity topologies. Synthesi., 55: 155-158.
15. Newkome, G. R., Yao, Z.-Q., Baker, G. R., and Gupta, V. K. (1985). Cascade molecules: A new approach to micelles. A [27]-arborol. J. Org. Chem., 50: 2003-2004.
16. Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Roeck, J., Ryder, J., and Smith, P. (1985). A new class of polymers: Starburst-dendritic macromolecules. Polym. J., 17: 117-132.
17. Tomalia, D. A., Naylor, A. M., and Goddard, W. A. I. (1990). Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. Eng., 29: 138-175.
18. Hawker, C. J., and Frechet, J. M. J. (1990). Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J. Am. Chem. Soc., 112: 7638-7647.
19. Tomalia, D. A., and Esfand, R. (1997). Dendrons, dendrimers, and dendri-grafts. Chem. Ind., 6: 416-420.
20. Frechet, J. M. J. (1994). Functional polymers and dendrimers: Reactivity, molecular architecture, and interfacial energy. Scienc., 263: 1710-1715.
21. Naylor, A. M., Goddard III, W. A., Kiefer, G. A., and Tomalia, D. A. (1989). Starburst dendrimers. 5. Molecular shape control. J. Am. Chem. Soc., 111: 2339-2341.
22. Jansen, J. F. G. A., deBrabander-vandenBerg, E. M. M., and Meijer, E. W. (1994). Encapsulation of guest molecules into a dendritic box. Science, 266: 1226-1229.
23. Stephan, H., Spies, H., Johannsen, B., Kauffmann, C., and Vogtle V. (2000). pH-controlled inclusion and release of oxyanions by dendrimers bearing methyl orange moieties. Org. Lett., 2: 2343-2346.
24. Singh, P. (1998). Terminal groups in Starburst dendrimers: activation and reactions with proteins. Bioconjug. Chem., 9: 54.
25. Scott, D. A., Krulle, T. M., Finn, M., and Fleet, G. W. J. (2000). Bis(., 3-dihydroxy-isopropyl)amine (BDI) as an AB4 dendritic building block: rapid synthesis of a second generation dendrimer. Tetrahedron Lett., 41: 3959.
26. Veprek, P., and Jezek, J. (1999). Peptide and glycopeptide dendrimers. Part II. J. Peptide Sci., 5: 203.
27. Wiwattanapatapee, R., Carreno-Gomez, B., Malik, N., and Duncan, R. (2000). Anionic PAMAM dendrimers rapidly cross adult rat intestines in vitro: A potential oral delivery system?Pharm. Res., 17: 991.
28. Sakthivel, T., Toth, I., and Florence, A. T. (1999). Distribution of a lipid 2.5 nm diameter dendrimer carrier after oral administration. Int. J. Pharm., 183: 51.
29. Florence, A. T., Sakthivel, T., and Toth, I. (2000). Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J. Controlled Release, 65: 253.
30. 125I-labelled polyamidoamine dendrimers in vivo. J. Controlled Releas., 65: 133.
31. Wiener, E. C., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., and Lauterbur, P. C. (1994). Dendrimer-based metal celates: A new class of magnetic resonance imaging contrast agents. Magn. Reson. Me., 31: 1.
32. Konda, S. D., Aref, M., Brechbiel, M., and Wiener, E. C. (2000). Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor. Invest. Radiol., 35: 50.
33. Liu, M., Kono, K., and Frechet, M. J. (2000). Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. J. Controlled Release, 65: 121.
34. Attia, S. A., Shepherd, V. E., Rosenblatt, M. N., Davidson, M. K., and Hughes, J. A. (1998). Interaction of oligodeoxynucleotides with mycobacteria: Implications for new therapeutic strategies. Antisense Nucleic Acid Drug Dev., 8: 207.
35. Reuter, J. D., Myc, A., Hayes, M. M., Gan, Z., Roy, R., Qin, D., Yin, R., Piehler, L. T., Esfand, R., Tomalia, D. A., and Baker, J. R. Jr. (1999). Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bioconjug. Chem., 10: 271.
36. Bourne, N., Stanberry, L. R., Kern, E. C., Holan, G., Matthews, B., and Bernstein, D. I. (2000). Dendrimers, a new class of candidate topical micro-bicides with activity against herpes simplex virus infection. Antimicrob. Agents Chemother., 44: 2471.
37. Barnard, D. L., Sidwell, R. W., Gage, T. L., Okleberry, K. M., Mathews, B., and Holan, G. (1997). Anti-respiratory syncytial virus activity of dendrimer polyanions. Antiviral Res., 34: A88.
38. Witvrouw, M., Pannecouque, C., Matthews, B., Schols, D., Andrei, G., Snoeck, R., Neyts, J., Leyssen, P., Desmyter, J., Raff, J., DeClerq, E., and Holan, G. (1999). Dendrimers inhibit the replication of human immunodeficiency virus (HIV) by a dual mechanism of action. Antiviral Res., 41: A41.
39. Duncan, R., and Malik, N. (1996). Dendrimers: biocompatibility and potential for delivery of anticancer agents. Proc. Int. Symp. Control Rel. Bioact. Mate., 23: 105.
40. Malik, N., Evagorou, E. G., and Duncan, R. (1999). Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drug., 10: 767.
41. Kojima, C., Kono, K., Maruyama, K., and Takagishi, T. (2000). Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem., 11: 910.
42. Vasey, P. A., Kaye, S. B., Morrison, R., Twelves, C., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., Burtles, S., Fraier, D., Frigerio, E., Cassidy, J., on behalf of the Cancer-Research Campaign Phase I/II Committee. (1999). Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents - drug-polymer conjugates. Clin. Cancer Res., 5: 83.
43. Cheng, H., Zhou, R., Liu, L., Du B., and Zhou, R. (2000). Cyclic core den-drimer as a new kind of vector for gene transfer into mammalian cells. Genetic., 108: 53.
44. Kukowska-Latallo, J. F., Bielinska, A. U., Chen, C., Rymaszewski, M., Tomalia, D. A., and Baker, J. R. Jr. (1998). Gene transfer using Starburst™ dendrimers. In Self-Assembling Complexes for Gene Delivery: From Laboratory to Clinical Trial. A. V. Kabanov, P. L. Felgner, and L. W. Seymour (eds.). John Wiley & Sons, Ltd., Chichester, p. 240.
45. Kukowska-Latallo, J. F., Bielinska, A. U., Johnson, J., Spindler, R., Tomalia, D. A., and Baker, J. R. Jr. (1996). Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. US., 93: 4897.
46. Bielinska, A., Kukowska-Latallo, J. F., Johnson, J., Tomalia, D. A., and Baker, J. R. Jr. (1996). Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res., 24: 2176.
47. Tang, M. X., and Szoka, F. C. (1997). The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther., 4: 823.
48. Bielinska, A. U., Kukowska-Latallo, J. F., and Baker, J. R. Jr. (1997). The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim. Biophys. Acta, 1353: 180.
49. Harada, Y., Iwai, M., Tanaka, S., Okanoue, T., Kashima, K., Maruyama-Tabata, H., Hirai, H., Satoh, E., Imanishi, J., and Mazda, O. (2000). Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer. Cancer Gene Ther., 7: 27.
50. Reddy, J. A., Dean, D., Kennedy, M. D., and Low, P. S. (1999). Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci., 88: 1112.
51. Barth, R. F., Adams, D. M., Soloway, A. H., Alam, F., and Darby, M. V. (1994). Boronated starburst dendrimer-monoclonal antibody immunoconju-gates: evaluation as a potential delivery system for neutron capture therapy. Bioconjug. Chem., 5: 58.
52. Yang, W., Barth, R. F., Adams, D. M., and Soloway, A. H. (1997). Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. Cancer Res., 57: 4333.
53. Qin, L., Pahud, D. R., Ding, Y., Bielinska, A. U., Kukowska-Latallo, J. F., Baker, J. R. Jr., and Bromberg, J. S. (1998). Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Human Gene The., 9: 553.
54. Brazeau, G. A., Attia, S., Poxon, S., and Hughes J. A. (1998). In vitro myo-toxicity of selected cationic macromolecules used in non-viral gene delivery. Pharm. Res., 15: 680.
55. de Smet, M. D., Meenken, C. J., and van den Horn, G. J. (1999). Fomivirsen-a phosphorothioate oligonucleotide for the treatment of CMV retinitis. Ocul. Immunol. Inflamm., 7: 189.
56. Perry, C. M., and Balfour, J. A. (1999). Fomivirsen. Drug., 57: 375.
57. Bochot, A., Couvreur, P., and Fattal, E. Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery. Prog. Retin. Eye Res., 19: 131.
58. Yoo, H., and Juliano, R. L. (2000). Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Re., 28: 4225.
59. Helin, V., Gottikh, M., Mishal, Z., Subra, F., Malvy, C., and Lavignon, M. (1999). Uptake and intracellular distribution of oligonucleotides vectorized by a PAMAM dendrimer. Nucleosides Nucleotide., 18: 1721.
60. Nilsen, T. W., Grayzel, J., and Prensky, W. (1997). Dendritic nucleic acid structures. J. Theor. Biol., 187: 273.
61. Goncz, K. K., Kunzelmann, K., Xu, Z., Gruenert, D. C. (1998). Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments. Hum. Mol. Genet., 7: 1913.
62. Bielinska, A. U., Yen, A., Wu, H. L., Zahos, K. M., Sun, R., Weiner, N. D., Baker, J. R. Jr., and Roessler, B. J. (2000). Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterial., 21: 877.
63. Kawase, M., Shiomi, T., Matsui, H., Ouji, Y., Higashiyama, S., Tsutsui, T., and Yagi, K. (2001). Suppression of apoptosis in hepatocytes by fructose-modified dendrimers. J. Biomed. Mater. Res., 54: 519.
64. Hudde, T., Rayner, S. A., Comer, R. M., Weber, M., Isaacs, J. D., Waldmann, H., Larkin, D. F. P., and George, A. J. T. (1999). Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium. Gene Ther.6: 939.
65. Henry, K., Cantrill, H., Fletcher, C., Chinnock, B. J., and Balfour, H. H. Jr. (1987). Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am. J. Ophthalmol., 103: 17.
66. Schwartz, D. M. (1996). New therapies for cytomegalovirus retinitis. Int. Ophthalmol. Clin., 36: 1.
67. Harris, M. L., and Mathalone, M. B. (1989). Intravitreal ganciclovir in CMV retinitis: Case report. Br. J. Ophthalmol., 73: 382.
68. Urtti, A., Polansky, J., Lui, G. M., and Szoka, F. C. (2000). Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix, and viral promoters. J. Drug. Target, 7: 413.
69. Maruyama-Tabata, H., Harada, Y., Matsumura, T., Satoh, E., Cui, F., Iwai, M., Kita, M., Hibi, S., Imanishi, J., Sawada, T., and Mazda, O. (2000). Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Ther., 7: 53.
70. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Buhler, K. R., and Vessella, R. L. (1998). Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodina-tion, and evaluation of biotinylated starburst dendrimers. Bioconjug. Chem., 9: 813.
71. Kono, K., Liu, M., and Frechet, J. M. (1999). Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjug. Chem., 10: 1115.
72. Thompson, J. P., and Schengrund, C. L. (1998). Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of Escherichia coli to cell surface GM1 by oligosaccharide-derivatized dendrimers. Biochem. Pharmacol., 56: 591.
73. Thompson, J. P., and Schengrund, C. L. (1997). Oligosaccharide-derivatized dendrimers: Defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1. Glycoconj. J., 14: 837.
74. Fishbein, I., Chorny, M., Rabinovich, L., Banai, S., Gati, I., and Golomb, G. (2000). Nanoparticle delivery system of a tyrphostin for the treatment of restenosis. J. Controlled Releas., 65: 221.
75. Benoit, J.-P., Faisant, N., Venier-Julienne, M.-C., and Menei, P. (2000). Development of microspheres for neurological disorders: From basics to clinical applications. J. Controlled Releas., 65: 285.
76. Bousif, O., Lezoulc’h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J.-P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. US., 92: 7297.